Side-by-side comparison of AI visibility scores, market position, and capabilities
Atlanta #3 US homebuilder (NYSE: PHM) at record $17.9B 2024 revenue, $3.1B net income, 31,219 closings; 27.5% gross margin, Hadrian X robotic bricklaying pilot (Feb 2025) competing with D.R. Horton and Lennar for new home buyers.
PulteGroup, Inc. is an Atlanta, Georgia-based residential homebuilder — publicly traded on the New York Stock Exchange (NYSE: PHM) as an S&P 500 Consumer Discretionary component — operating as the third-largest US homebuilder with 800,000+ homes delivered since founding across 45 markets in 23 states through three brand tiers: Pulte Homes (move-up and multi-generational buyers), Centex (value-focused first-time buyers), and Del Webb (active adult communities for buyers 55 and over). In fiscal year 2024, PulteGroup reported record revenues of $17.9 billion, record net income of $3.1 billion, and closed 31,219 homes (up 7% year-over-year) — while maintaining industry-leading gross margins of 27.5% and return on equity of 27.5%. Q4 2024 net income was $913 million ($4.43 per share). PulteGroup guided to approximately 29,000 home closings in 2025 with $5 billion in land acquisition and development investment. In February 2025, PulteGroup deployed the Hadrian X AI-guided robotic bricklaying system in Florida — an automated wall construction robot that lays 200-300 bricks per hour using CAD-to-construction technology — reducing labor-intensive masonry work and construction cycle times. Founded in 1950 by William J. Pulte (at age 18 in Michigan), PulteGroup grew through seven decades and strategic acquisitions of DiVosta Homes (2001), Centex Corporation ($3.1B, 2009), and John Wieland Homes and Neighborhoods (2016) to become a Fortune 200 company.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.